BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Allakos Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-19 6:42 pm Sale | 2025-05-15 | 13G | Allakos Inc. ALLK | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -16,552,417 (Position Closed) | Filing |
| 2024-01-18 4:32 pm Purchase | 2024-01-16 | 13G | Allakos Inc. ALLK | BIOTECHNOLOGY VALUE FUND L P | 16,552,417 18.900% | 8,000,000 (+93.54%) | Filing |
| 2024-01-18 4:29 pm Purchase | 2023-12-31 | 13G | Allakos Inc. ALLK | BIOTECHNOLOGY VALUE FUND L P | 8,552,417 9.800% | 3,545,496 (+70.81%) | Filing |
| 2022-09-29 4:28 pm Purchase | 2022-09-19 | 13G | Allakos Inc. ALLK | BIOTECHNOLOGY VALUE FUND L P | 5,006,921 5.900% | 5,006,921 (New Position) | Filing |